Comparison of SARS-CoV-2 immune responses following vaccination with Comirnaty (Pfizer) and Vaxzevria (AstraZeneca) in healthy individuals with or without prior SARS-CoV-2 infection
IntroductionThis study compares the immune responses of healthy individuals, with or without prior SARS-CoV-2 infection, following vaccination with Comirnaty (Pfizer) and Vaxzevria (AstraZeneca).MethodsA total of 134 volunteers were analyzed: 71 recipients of Comirnaty (36 with prior infection) and...
Saved in:
| Main Authors: | Zdzisława Kondera-Anasz, Emilia Justyna Morawiec, Roksana Duszkiewicz, Filip Hajdrowski, Andrzej Wiczkowski |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1612288/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effectiveness of ChAdOx1 nCoV-19 (Vaxzevria) primary series vaccine against SARS-CoV-2 beta and delta variants: a nationwide study
by: Hiam Chemaitelly, et al.
Published: (2025-08-01) -
Protection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong
by: Jialiang Jiang, et al.
Published: (2025-12-01) -
Comparative analysis of humoral immunity kinetics following three COVID-19 vaccines in a multi-ethnic cohort of medical students and healthcare professionals across Malaysia
by: Ashwathy Varadarajan Thundakattil, et al.
Published: (2025-07-01) -
New-onset cutaneous lichen planus following Vaxzevria (Oxford-AstraZeneca) COVID-19 vaccination
by: Amira Muftah, et al.
Published: (2024-12-01) -
SCB-2019 protein vaccine as heterologous booster of neutralizing activity against SARS-CoV-2 Omicron variants after immunization with other COVID-19 vaccines
by: Camilo C. Roa, et al.
Published: (2024-12-01)